{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,29]],"date-time":"2026-03-29T20:57:14Z","timestamp":1774817834188,"version":"3.50.1"},"reference-count":65,"publisher":"Public Library of Science (PLoS)","issue":"12","license":[{"start":{"date-parts":[[2012,12,14]],"date-time":"2012-12-14T00:00:00Z","timestamp":1355443200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0049732","type":"journal-article","created":{"date-parts":[[2012,12,14]],"date-time":"2012-12-14T22:23:36Z","timestamp":1355523816000},"page":"e49732","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":29,"title":["Blinded Prospective Evaluation of Computer-Based Mechanistic Schizophrenia Disease Model for Predicting Drug Response"],"prefix":"10.1371","volume":"7","author":[{"given":"Hugo","family":"Geerts","sequence":"first","affiliation":[]},{"given":"Athan","family":"Spiros","sequence":"additional","affiliation":[]},{"given":"Patrick","family":"Roberts","sequence":"additional","affiliation":[]},{"given":"Roy","family":"Twyman","sequence":"additional","affiliation":[]},{"given":"Larry","family":"Alphs","sequence":"additional","affiliation":[]},{"given":"Anthony A.","family":"Grace","sequence":"additional","affiliation":[]}],"member":"340","published-online":{"date-parts":[[2012,12,14]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"e04","DOI":"10.4088\/JCP.0207e04","article-title":"Effectiveness of antipsychotic drugs in patients with chronic schizophrenia: efficacy, safety and cost outcomes of CATIE and other trials","volume":"68","author":"JA Lieberman","year":"2007","journal-title":"J Clin Psychiatry"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1093\/schbul\/sbp133","article-title":"Review of pathological hallmarks of schizophrenia: comparison of genetic models with patients and nongenetic models","volume":"36","author":"H Jaaro-Peled","year":"2010","journal-title":"Schizophr Bull"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"8104","DOI":"10.1073\/pnas.97.14.8104","article-title":"Increased baseline occupancy of D<sub>2<\/sub> receptors by dopamine in schizophrenia","volume":"97","author":"A Abi-Dargham","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1038\/nn804","article-title":"Reduced prefrontal activity predicts exaggerated striatal dopaminergic function in schizophrenia","volume":"5","author":"A Meyer-Lindenberg","year":"2002","journal-title":"Nat Neurosci"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"898","DOI":"10.4088\/JCP.v64n0807","article-title":"An integrated analysis of acute treatment-emergent extrapyramidal syndrome in patients with schizophrenia during olanzapine clinical trials: comparisons with placebo, haloperidol, risperidone, or clozapine","volume":"64","author":"CD Carlson","year":"2003","journal-title":"J Clin Psychiatry"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S0006-3223(97)00190-X","article-title":"Multiple fixed doses of \u201cSeroquel\u201d (quetiapine) in patients with acute exacerbation of schizophrenia: a comparison with haloperidol and placebo. The Seroquel Trial 13 Study Group","volume":"42","author":"LA Arvanitis","year":"1997","journal-title":"Biol Psychiatry"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.pnpbp.2003.11.015","article-title":"Comparison of risperidone and olanzapine as used under \u201creal-world\u201d conditions in a state psychiatric hospital","volume":"28","author":"C Advokat","year":"2004","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1017\/S0033291799001476","article-title":"A multicentre, double-blind, randomized comparison of quetiapine (ICI 204,636, \u2018Seroquel\u2019) and haloperidol in schizophrenia","volume":"30","author":"DL Copolov","year":"2000","journal-title":"Psychol Med"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1002\/ddr.21008","article-title":"A quantitative systems pharmacology computer model for schizophrenia efficacy and extrapyramidal side-effects","volume":"73","author":"A Spiros","year":"2012","journal-title":"Drug Develop Res"},{"key":"ref10","first-page":"589","article-title":"Not all partial dopamine D(2) receptor agonists are the same in treating schizophrenia. Exploring the effects of bifeprunox and aripiprazole using a computer model of a primate striatal dopaminergic synapse","volume":"6","author":"A Spiros","year":"2010","journal-title":"Neuropsychiatr Dis Treat"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.tins.2008.02.005","article-title":"Circuit-based framework for understanding neurotransmitter and risk gene interactions in schizophrenia","volume":"31","author":"JE Lisman","year":"2008","journal-title":"Trends Neurosci"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/S0165-0173(99)00049-1","article-title":"Gating of information flow within the limbic system and the pathophysiology of schizophrenia","volume":"31","author":"AA Grace","year":"2000","journal-title":"Brain Res Brain Res Rev"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1162\/neco.1997.9.6.1179","article-title":"The NEURON simulation environment","volume":"9","author":"ML Hines","year":"1997","journal-title":"Neural Comput"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/npp.2009.146","article-title":"Neurocircuitry: a window into the networks underlying neuropsychiatric disease","volume":"35","author":"SN Haber","year":"2010","journal-title":"Neuropsychopharmacology"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"8156","DOI":"10.1523\/JNEUROSCI.3905-08.2009","article-title":"Impact of serotonin 2C receptor null mutation on physiology and behavior associated with nigrostriatal dopamine pathway function","volume":"29","author":"L Abdallah","year":"2009","journal-title":"J Neurosci"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1046\/j.1460-9568.2003.02512.x","article-title":"Conditional involvement of striatal serotonin3 receptors in the control of in vivo dopamine outflow in the rat striatum","volume":"17","author":"G Porras","year":"2003","journal-title":"Eur J Neurosci"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1152\/jn.00853.2004","article-title":"Cholinergic control of firing pattern and neurotransmission in rat neostriatal projection neurons: role of CaV2.1 and CaV2.2 Ca2+ channels","volume":"93","author":"T Perez-Rosello","year":"2005","journal-title":"J Neurophysiol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"7449","DOI":"10.1523\/JNEUROSCI.1381-05.2005","article-title":"Cholinergic suppression of KCNQ channel currents enhances excitability of striatal medium spiny neurons","volume":"25","author":"W Shen","year":"2005","journal-title":"J Neurosci"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"3351","DOI":"10.1523\/JNEUROSCI.14-05-03351.1994","article-title":"Distribution of m1-m4 muscarinic receptor proteins in the rat striatum: light and electron microscopic immunocytochemistry using subtype-specific antibodies","volume":"14","author":"SM Hersch","year":"1994","journal-title":"J Neurosci"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/sj.npp.1300297","article-title":"Stress impairs alpha(1A) adrenoceptor-mediated noradrenergic facilitation of GABAergic transmission in the basolateral amygdala","volume":"29","author":"MF Braga","year":"2004","journal-title":"Neuropsychopharmacology"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.neuroscience.2008.04.075","article-title":"Over-expression of the potassium channel Kir2.3 using the dopamine-1 receptor promoter selectively inhibits striatal neurons","volume":"155","author":"T Falk","year":"2008","journal-title":"Neuroscience"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1124\/mol.62.1.119","article-title":"Classic D1 dopamine receptor antagonist R-(+)-7-chloro-8-hydroxy-3-methyl-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzaze pine hydrochloride (SCH23390) directly inhibits G protein-coupled inwardly rectifying potassium channels","volume":"62","author":"EV Kuzhikandathil","year":"2002","journal-title":"Mol Pharmacol"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1152\/jn.00618.2002","article-title":"Modulation of striatal single units by expected reward: a spiny neuron model displaying dopamine-induced bistability","volume":"90","author":"AJ Gruber","year":"2003","journal-title":"J Neurophysiol"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"6650","DOI":"10.1523\/JNEUROSCI.18-17-06650.1998","article-title":"Inwardly rectifying potassium (IRK) currents are correlated with IRK subunit expression in rat nucleus accumbens medium spiny neurons","volume":"18","author":"PG Mermelstein","year":"1998","journal-title":"J Neurosci"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1162\/neco.1997.9.6.1179","article-title":"The NEURON simulation environment","volume":"9","author":"ML Hines","year":"1997","journal-title":"Neural Comput"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"9541","DOI":"10.1523\/JNEUROSCI.2891-04.2004","article-title":"Dopamine modulates release from corticostriatal terminals","volume":"24","author":"NS Bamford","year":"2004","journal-title":"J Neurosci"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1001\/archpsyc.1997.01830150047009","article-title":"Mesolimbic dopamine D3 receptors and use of antipsychotics in patients with schizophrenia. A postmortem study","volume":"54","author":"EV Gurevich","year":"1997","journal-title":"Arch Gen Psychiatry"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1007\/s00381-002-0604-1","article-title":"Functional anatomy of thalamus and basal ganglia","volume":"18","author":"MT Herrero","year":"2002","journal-title":"Childs Nerv Syst"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/S0306-4522(01)00199-3","article-title":"A major role for thalamocortical afferents in serotonergic hallucinogen receptor function in the rat neocortex","volume":"105","author":"GJ Marek","year":"2001","journal-title":"Neuroscience"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/S0006-8993(02)03727-7","article-title":"The 5-HT1A serotonin receptor is located on calbindin- and parvalbumin-containing neurons in the rat brain","volume":"959","author":"S Aznar","year":"2003","journal-title":"Brain Res"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1126\/science.1167093","article-title":"Optical deconstruction of parkinsonian neural circuitry","volume":"324","author":"V Gradinaru","year":"2009","journal-title":"Science"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"6846","DOI":"10.1523\/JNEUROSCI.22-16-06846.2002","article-title":"Serotonin receptor activation inhibits sodium current and dendritic excitability in prefrontal cortex via a protein kinase C-dependent mechanism","volume":"22","author":"DB Carr","year":"2002","journal-title":"J Neurosci"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1152\/jn.1996.75.2.648","article-title":"Serotonin modulates N- and P-type calcium currents in neocortical pyramidal neurons via a membrane-delimited pathway","volume":"75","author":"RC Foehring","year":"1996","journal-title":"J Neurophysiol"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.expneurol.2004.05.009","article-title":"Effects of stimulation of the subthalamic area on oscillatory pallidal activity in Parkinson&apos;s disease","volume":"188","author":"P Brown","year":"2004","journal-title":"Exp Neurol"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/S0306-4522(99)00583-7","article-title":"Single-unit analysis of the pallidum, thalamus and subthalamic nucleus in parkinsonian patients","volume":"96","author":"M Magnin","year":"2000","journal-title":"Neuroscience"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1001\/archpsyc.60.3.311","article-title":"Up-regulation of the D1 dopamine receptor-interacting protein, calcyon, in patients with schizophrenia","volume":"60","author":"PO Koh","year":"2003","journal-title":"Arch Gen Psychiatry"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1007\/s002130000532","article-title":"Increased dopamine D2 receptor binding after long-term treatment with antipsychotics in humans: a clinical PET study","volume":"152","author":"S Silvestri","year":"2000","journal-title":"Psychopharmacology (Berl)"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0920-9964(00)00095-5","article-title":"Decreased striatal dopamine transporter binding in vivo in chronic schizophrenia","volume":"52","author":"A Laakso","year":"2001","journal-title":"Schizophr Res"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0165-0173(03)00153-X","article-title":"Ten years of antisense inhibition of brain G-protein-coupled receptor function","volume":"42","author":"D Van Oekelen","year":"2003","journal-title":"Brain Res Brain Res Rev"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1016\/j.lfs.2005.06.038","article-title":"No change in cortical muscarinic M2, M3 receptors or [35S]GTPgammaS binding in schizophrenia","volume":"78","author":"E Scarr","year":"2006","journal-title":"Life Sci"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1124\/jpet.111.190702","article-title":"Pharmacology of JNJ-37822681, a specific and fast-dissociating D2 antagonist for the treatment of schizophrenia","volume":"342","author":"X Langlois","year":"2012","journal-title":"J Pharmacol Exp Ther"},{"key":"ref42","article-title":"A double-blind, randomized, placebo-controlled study with JNJ-37822681, a novel, highly selective, fast dissociating D92) receptor antagonist in the treatment of acute exacerbation of schizophrenia","volume":"30","author":"ME Schmidt","year":"2012","journal-title":"Eur Neuropsycholopharmacol"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1176\/ajp.156.6.876","article-title":"Rapid release of antipsychotic drugs from dopamine D2 receptors: an explanation for low receptor occupancy and early clinical relapse upon withdrawal of clozapine or quetiapine","volume":"156","author":"P Seeman","year":"1999","journal-title":"Am J Psychiatry"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1177\/070674370204700106","article-title":"Atypical antipsychotics: mechanism of action","volume":"47","author":"P Seeman","year":"2002","journal-title":"Can J Psychiatry"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1016\/j.bmc.2011.02.033","article-title":"Molecular properties affecting fast dissociation from the D2 receptor","volume":"19","author":"G Tresadern","year":"2011","journal-title":"Bioorg Med Chem"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/S0026-895X(25)08945-X","article-title":"In vitro and in vivo receptor binding and effects on monoamine turnover in rat brain regions of the novel antipsychotics risperidone and ocaperidone","volume":"41","author":"JE Leysen","year":"1992","journal-title":"Mol Pharmacol"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1001\/archpsyc.60.12.1228","article-title":"Delayed-onset hypothesis of antipsychotic action: a hypothesis tested and rejected","volume":"60","author":"O Agid","year":"2003","journal-title":"Arch Gen Psychiatry"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.pscychresns.2006.05.009","article-title":"Dopamine D2 receptor binding in drug-naive patients with schizophrenia examined with raclopride-C11 and positron emission tomography","volume":"148","author":"M Talvik","year":"2006","journal-title":"Psychiatry Res"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1136\/bmj.321.7273.1371","article-title":"Atypical antipsychotics in the treatment of schizophrenia: systematic overview and meta-regression analysis","volume":"321","author":"J Geddes","year":"2000","journal-title":"Br Med J"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1001\/archpsyc.60.6.553","article-title":"A meta-analysis of the efficacy of second-generation antipsychotics","volume":"60","author":"JM Davis","year":"2003","journal-title":"Arch Gen Psychiatry"},{"key":"ref51","doi-asserted-by":"crossref","DOI":"10.1176\/ajp.155.7.921","article-title":"5-HT2 and D2 receptor occupancy of olanzapine in schizophrenia: a PET investigation","volume":"155","author":"S Kapur","year":"1998","journal-title":"Am J Psychiatry"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1017\/S1461145798001229","article-title":"D(2)- and 5-HT(2) receptor occupancy in high-dose neuroleptic-treated patients","volume":"1","author":"S Nyberg","year":"1998","journal-title":"Int J Neuropsychopharmacol"},{"key":"ref53","first-page":"829","article-title":"Dosing and switching strategies for paliperidone palmitate: based on population pharmacokinetic modelling and clinical trial data","volume":"25","author":"MN Samtani","year":"2011","journal-title":"CNS Drugs"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/0006-3223(93)90288-O","article-title":"Central D2-dopamine receptor occupancy in relation to antipsychotic drug effects: a double-blind PET study of schizophrenic patients","volume":"33","author":"AL Nordstrom","year":"1993","journal-title":"Biol Psychiatry"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"915","DOI":"10.2165\/11310890-000000000-00000","article-title":"Of mice and men: bridging the translational disconnect in CNS drug discovery","volume":"23","author":"H Geerts","year":"2009","journal-title":"CNS Drugs"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1590\/S0004-282X2009000300007","article-title":"The use of an antagonist 5-HT2a\/c for depression and motor function in Parkinson&apos; disease","volume":"67","author":"AL Werneck","year":"2009","journal-title":"Arq Neuropsiquiatr"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1111\/j.1600-0447.1990.tb05299.x","article-title":"A double blind comparative multicentre study of remoxipride and haloperidol in schizophrenia","volume":"Suppl 358","author":"J Andersen","year":"1990","journal-title":"Acta Psychiatr Scand"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/S0022-3565(25)11204-4","article-title":"Pharmacological profile of the new potent neuroleptic ocaperidone (R 79,598)","volume":"260","author":"AA Megens","year":"1992","journal-title":"J Pharmacol Exp Ther"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1093\/schbul\/sbn110","article-title":"What is causing the reduced drug-placebo difference in recent schizophrenia clinical trials and what can be done about it?","volume":"36","author":"AS Kemp","year":"2010","journal-title":"Schizophr Bull"},{"key":"ref60","first-page":"1","article-title":"Placebo-related effects in clinical trials in schizophrenia: what is driving this phenomenon and what can be done to minimize it?","author":"L Alphs","year":"2012","journal-title":"Int J Neuropsychopharmacol"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1517\/14656566.9.9.1451","article-title":"Antipsychotic-induced extrapyramidal symptoms and their management","volume":"9","author":"P Dayalu","year":"2008","journal-title":"Expert Opin Pharmacother"},{"key":"ref62","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1001\/archpsyc.1994.03950120035007","article-title":"Clinical characteristics and predisposing factors in acute drug-induced akathisia","volume":"51","author":"P Sachdev","year":"1994","journal-title":"Arch Gen Psychiatry"},{"key":"ref63","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1385\/NI:4:1:21","article-title":"Imaging phenotypes and genotypes in schizophrenia","volume":"4","author":"JA Turner","year":"2006","journal-title":"Neuroinformatics"},{"key":"ref64","doi-asserted-by":"crossref","first-page":"2963","DOI":"10.1523\/JNEUROSCI.22-07-02963.2002","article-title":"Activity patterns in a model for the subthalamopallidal network of the basal <underline>ganglia<\/underline>","volume":"22","author":"D Terman","year":"2002","journal-title":"J Neurosci"},{"key":"ref65","unstructured":"Sorger PK, Allerheiligen SRB, Abernethy DR, Altman RB, Brouwer KLR, <etal>et al<\/etal>.. (2011) Quantitative and systems pharmacology in the post-genomic era: New approaches to discovering drugs and understanding therapeutic mechanisms. Available: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.scribd.com\/doc\/71263148\/systems\" xlink:type=\"simple\">http:\/\/www.scribd.com\/doc\/71263148\/systems<\/ext-link>. Accessed 9 May 2012."}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0049732","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T18:44:30Z","timestamp":1745433870000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0049732"}},"subtitle":[],"editor":[{"given":"Daniel","family":"Durstewitz","sequence":"first","affiliation":[]}],"short-title":[],"issued":{"date-parts":[[2012,12,14]]},"references-count":65,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2012,12,14]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0049732","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,12,14]]}}}